SiriusPoint Ltd. (SPNT)
Automate Your Wheel Strategy on SPNT
With Tiblio's Option Bot, you can configure your own wheel strategy including SPNT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SPNT
- Rev/Share 16.4186
- Book/Share 13.0551
- PB 1.4017
- Debt/Equity 0.3355
- CurrentRatio 0.0
- ROIC -0.0075
- MktCap 2135540400.0
- FreeCF/Share 0.8372
- PFCF 15.8071
- PE 17.3931
- Debt/Assets 0.0572
- DivYield 0
- ROE 0.0775
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 3
- P/B Score 2
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | SPNT | B. Riley Securities | -- | Buy | -- | $33 | July 21, 2025 |
| Initiation | SPNT | Oppenheimer | -- | Outperform | -- | $25 | June 26, 2025 |
| Initiation | SPNT | Jefferies | -- | Hold | -- | $17 | April 15, 2025 |
News
Should Value Investors Buy SiriusPoint (SPNT) Stock?
Published: August 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Wall Street Analysts See a 29.37% Upside in SiriusPoint (SPNT): Can the Stock Really Move This High?
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Positive
The consensus price target hints at a 29.4% upside potential for SiriusPoint (SPNT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read More
SiriusPoint: A Reinsurance Underdog Set For A Breakout
Published: July 29, 2025 by: Seeking Alpha
Sentiment: Positive
SiriusPoint has successfully executed a strategic turnaround, improving underwriting discipline and restoring profitability since 2023 despite catastrophe losses. The company's book value per share has grown 31% since Q4 2022, supporting a potential re-rating to 1.3–1.4x P/B and 30% upside. Forward P/E of 9.3 is below the industry average, indicating undervaluation if underwriting margins and net income remain stable or improve.
Read More
Analysts Estimate SiriusPoint (SPNT) to Report a Decline in Earnings: What to Look Out for
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Negative
SiriusPoint (SPNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Are Investors Undervaluing SiriusPoint (SPNT) Right Now?
Published: July 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Is SiriusPoint (SPNT) Stock Undervalued Right Now?
Published: July 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
SiriusPoint And Its Preferred Stock Are Underrated Opportunities In The Insurance Sector
Published: July 02, 2025 by: Seeking Alpha
Sentiment: Positive
SiriusPoint has outperformed the S&P 500 and peers, highlighting strong management and market position. The company boasts investment-grade credit ratings, reinforcing its financial strength and reliability as a preferred equity issuer. SPNT.PR.B preferred stock offers a high 7.01% yield to call, resettable rate, and growth potential, appealing to long-term income investors.
Read More
SiriusPoint Ltd. (SPNT) Q1 2025 Earnings Call Transcript
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral
SiriusPoint Ltd. (NYSE:SPNT ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Liam Blackledge - Investor Relations & Strategy Manager Scott Egan - Chief Executive Officer Jim McKinney - Chief Financial Officer Operator Good morning, ladies and gentlemen, and welcome to SiriusPoint's First Quarter 2025 Earnings Conference Call.
Read More
SiriusPoint Announces Pricing of Secondary Offering of 4,106,631 Common Shares by Entities Associated with Daniel S. Loeb and Repurchase of 500,000 Shares by SiriusPoint
Published: February 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
HAMILTON, Bermuda, Feb. 25, 2025 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT) today announced the pricing of its previously announced registered secondary offering by entities associated with Daniel S. Loeb (colllectively, the “Loeb Entities”) of an aggregate of 4,106,631 common shares at a price to the public of $14.00 per share. The offering is expected to close on February 27, 2025, subject to the satisfaction of customary closing conditions.
Read More
SiriusPoint Ltd. (SPNT) Q4 2024 Earnings Call Transcript
Published: February 19, 2025 by: Seeking Alpha
Sentiment: Neutral
SiriusPoint Ltd. (NYSE:SPNT ) Q4 2024 Earnings Conference Call February 19, 2025 8:30 AM ET Company Participants Liam Blackledge - Senior Associate, Investor Relations & Strategy Scott Egan - Chief Executive Officer Jim McKinney - Chief Financial Officer Conference Call Participants Operator Good morning, ladies and gentlemen and welcome to SiriusPoint's Fourth Quarter 2024 Earnings Conference Call.
Read More
About SiriusPoint Ltd. (SPNT)
- IPO Date 2013-08-15
- Website https://www.siriuspt.com
- Industry Insurance - Reinsurance
- CEO Scott Egan ACMA, MBA
- Employees 1012